163 related articles for article (PubMed ID: 19512962)
1. Acute hemifacial dystonia possibly induced by clebopride.
Bosco D; Plastino M; Marcello MG; Mungari P; Fava A
Clin Neuropharmacol; 2009; 32(2):107-8. PubMed ID: 19512962
[TBL] [Abstract][Full Text] [Related]
2. An acute dystonic reaction with long-term use of ranitidine in an intensive care unit patient.
Wilson LB; Woodward AM; Ferrara JJ
J La State Med Soc; 1997 Jan; 149(1):36-8. PubMed ID: 9033194
[TBL] [Abstract][Full Text] [Related]
3. [Tardive dystonia following the administration of clebopride].
Sempere AP; Mola S; Flores J
Rev Neurol; 1997 Dec; 25(148):2060. PubMed ID: 9528065
[No Abstract] [Full Text] [Related]
4. Acute dystonic reaction induced by a single dose of clebopride: A case report.
Seo YW; Ko SH; Jang TC; Kim GM
Medicine (Baltimore); 2019 May; 98(22):e15826. PubMed ID: 31145322
[TBL] [Abstract][Full Text] [Related]
5. Progressive supranuclear palsy syndrome induced by clebopride.
Campdelacreu J; Kumru H; Tolosa E; Valls-Solé J; Benabarre A
Mov Disord; 2004 Apr; 19(4):482-4. PubMed ID: 15077251
[TBL] [Abstract][Full Text] [Related]
6. Persistent parkinsonism and tardive dyskinesia induced by clebopride.
Jiménez-Jiménez FJ; Cabrera-Valdivia F; Ayuso-Peralta L; Tejeiro J; Vaquero A; García-Albea E
Mov Disord; 1993 Apr; 8(2):246-7. PubMed ID: 8474508
[No Abstract] [Full Text] [Related]
7. [Drug-induced extrapyramidal syndrome. Apropos of 22 cases].
López Rois F; Couce Pico M; Calvo Fernández J; Novo I; Castro-Gago M
An Esp Pediatr; 1987 Feb; 26(2):91-3. PubMed ID: 3565961
[TBL] [Abstract][Full Text] [Related]
8. Parkinsonism and tardive dyskinesia after chronic use of clebopride.
Sempere AP; Duarte J; Palomares JM; Coria F; Clavería LE
Mov Disord; 1994 Jan; 9(1):114-5. PubMed ID: 8166880
[No Abstract] [Full Text] [Related]
9. Treatment of generalized tardive dystonia with clozapine.
Aukst-Margetić B; Margetić B
Psychiatr Danub; 2008 Sep; 20(3):329-31. PubMed ID: 18827758
[TBL] [Abstract][Full Text] [Related]
10. [A case of respiratory dyskinesia due to clebopride malate].
Kawasaki H; Yamamoto M; Okayasu H; Wakayama Y
Rinsho Shinkeigaku; 1991 Aug; 31(8):878-81. PubMed ID: 1764865
[TBL] [Abstract][Full Text] [Related]
11. Acute dystonic reaction associated with foscarnet administration.
Dubow JS; Panush SR; Rezak M; Leikin J
Am J Ther; 2008; 15(2):184-6. PubMed ID: 18356641
[TBL] [Abstract][Full Text] [Related]
12. Transient dyskinesia induced by clebopride.
Martínez-Martín P
Mov Disord; 1993; 8(1):125-6. PubMed ID: 8419802
[No Abstract] [Full Text] [Related]
13. Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia.
Iselin-Chaves IA; Grötzsch H; Besson M; Burkhard PR; Savoldelli GL
Anaesthesia; 2009 Dec; 64(12):1359-62. PubMed ID: 19839983
[TBL] [Abstract][Full Text] [Related]
14. Etiological and therapeutical observations in a case of belly dancer's dyskinesia.
Linazasoro G; Van Blercom N; Lasa A; Fernández JM; Aranzábal I
Mov Disord; 2005 Feb; 20(2):251-3. PubMed ID: 15455446
[TBL] [Abstract][Full Text] [Related]
15. Acute oculogyric crisis in a patient taking clebopride.
Kim W; Lee KS; Kim YI; Kim JS
Intern Med; 2008; 47(6):551-2. PubMed ID: 18344644
[TBL] [Abstract][Full Text] [Related]
16. [Acute laryngeal dystonia due to clebopride simulating allergic reaction].
Corominas Sánchez M; Lleonart Bellfill R; Pujol Farriols R
Med Clin (Barc); 2007 Jul; 129(6):238-9. PubMed ID: 17678608
[No Abstract] [Full Text] [Related]
17. [Clebopride and the extrapyramidal syndrome].
Sanz Amaro A
An Esp Pediatr; 1987 Dec; 27(6):485. PubMed ID: 3447504
[No Abstract] [Full Text] [Related]
18. Parkinsonian syndrome after long-term treatment with clebopride.
Montagna P; Gabellini AS; Monari L; Lugaresi E
Mov Disord; 1992; 7(1):89-90. PubMed ID: 1557073
[No Abstract] [Full Text] [Related]
19. Acute Cervical Dystonia Induced by Clebopride.
Choi JK; Hong JY
Case Rep Neurol Med; 2017; 2017():2834349. PubMed ID: 29333306
[TBL] [Abstract][Full Text] [Related]
20. [Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System].
Cuena Boy R; Maciá Martínez MA
Aten Primaria; 1998 Mar; 21(5):289-95. PubMed ID: 9608114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
